genome-engineering/prime-editing-design/SKILL.md
Designs pegRNAs and nicking guides for prime editing (PE) -- choosing the nick/strand, tuning the primer-binding site (PBS) and reverse-transcription template (RTT) as a per-locus panel, selecting the PE system (PE2/PE3/PE3b/PE4/PE5/PEmax/PE7), adding MMR-evading and PAM-disrupting silent edits, appending epegRNA 3' motifs (tevopreQ1/mpknot), and ranking with PRIDICT/DeepPrime. Covers twinPE/PASTE for large insertions and the prime-vs-base-editing decision. Use when designing a scarless point mutation, small insertion/deletion, or any of the 12 base conversions without a double-strand break, when efficiency is low and MMR inhibition or pegRNA stabilization is needed, or when routing a large insertion to an integrase method. Generic guide scoring and base editing are separate skills.
npx skillsauth add GPTomics/bioSkills bio-genome-engineering-prime-editing-designInstall this skill globally with one command. Works with Claude Code, Cursor, and Windsurf.
3 of 9 scanners reported clean
Some scanners were skipped, did not run, or reported a non-clean status. Review each row below.
Reference examples tested with: BioPython 1.83+, PrimeDesign 1.2+ (Docker), PRIDICT2.0 (web/code).
Before using code patterns, verify installed versions match. If versions differ:
pip show <package> then help(module.function) to check signatures<tool> --version then <tool> --help to confirm flagsIf code throws ImportError, AttributeError, or TypeError, introspect the installed package and adapt the example to match the actual API rather than retrying.
PrimeDesign is Docker-only (no pip) and takes the edit inline in a single string with exact parenthesis notation (below) -- the most-hallucinated thing in PE tooling; verify it against the repo, never reconstruct from memory. Outcome-prediction models are trained mostly on HEK293T + small edits (<=3 bp); their scores are priors, not measurements, and degrade off-distribution. The PE system (MMR status, expressed vs synthetic pegRNA) drives efficiency more than any oligo tweak.
"Install a precise small edit without a double-strand break" -> Establish the edit, cell type, MMR status, and delivery; choose the nick position/strand; design a panel of PBS x RTT combinations; pick the PE system; add the free wins (PAM-disrupting + MMR-evading silent edits, a 3' motif); rank with a model; and test.
PrimeDesign generates ranked pegRNA + nicking-guide components from a reference + edit stringBio.Seq; enforce the don't-end-on-C and 5'-G rulesTwo reframes:
PBS and RTT length are parameters to optimize per locus, not constants to look up. The PBS x RTT optimum is locus-specific -- it depends on local GC (which sets the PBS annealing Tm), the edit, the nick-to-edit distance, and chromatin. A high-GC target wants a short PBS; a low-GC target a long one; the "13/15" that is perfect at one locus is useless 200 bp away. A hard-coded default produces a sequence that looks valid, so nothing flags it until the data come back at 2%. The correct deliverable is a ranked panel (a few PBS x a few RTT x the viable nicks), tested or model-ranked -- emitting a single pegRNA is the tell of someone who has never run PE.
Prime editing efficiency is a cellular-genetics problem, not just oligo design. The cell's mismatch repair (MMR; MutSalpha/MutLalpha) detects the edit:original heteroduplex and excises the edited strand, reverting it and spawning indels. The biggest post-2019 jump was not a better PBS -- it was inhibiting MMR (MLH1dn -> PE4/PE5, ~7.7x average). The second was stopping the pegRNA 3' end from being degraded (epegRNA motifs; PE7's La protein). Design now means choosing the system (PE2 vs PE3b vs PE5max+epegRNA vs PE7) as much as the sequence. First branch: what edit, what cell type, MMR-proficient or not, expressed or synthetic.
The prime editor (Anzalone 2019) is Cas9 H840A nickase + engineered M-MLV reverse transcriptase, programmed by a pegRNA = sgRNA (spacer + scaffold) with a 3' extension read 5'->3' as [RTT][PBS]. (1) The nickase cuts the protospacer (PAM) strand ~3 nt 5' of the PAM, exposing a free 3'-OH. (2) The PBS anneals to that nicked 3' end (the genomic strand becomes the primer). (3) The RT extends through the RTT, synthesizing a new 3' DNA flap that encodes the edit. (4) FEN1-type nucleases preferentially excise the unedited 5' flap, favoring incorporation of the edited 3' flap; ligation seals it. (5) The resulting heteroduplex is resolved by MMR -- which preferentially reverts the edit (hence the MMR section below). Consequences: PBS length is tuned by annealing Tm; RTT length = nick-to-edit distance + edit + 3' homology tail (~10-16 nt); efficiency falls as the edit moves farther from the nick; the edit must lie within the RTT.
| System | Adds over previous | Acts on | Cite | |--------|--------------------|---------|------| | PE1 | Cas9 H840A + wild-type M-MLV RT | proof of concept | Anzalone 2019 | | PE2 | engineered M-MLV RT (pentamutant) | the workhorse enzyme | Anzalone 2019 | | PE3 | + second nicking sgRNA on the non-edited strand (~1.5-4x) | flap resolution / MMR strand bias -- but raises indels (transient near-DSB) | Anzalone 2019 | | PE3b | PE3 ngRNA matching only the edited sequence -> nick fires after the edit | near-eliminates PE3's indels; only possible when the edit makes/breaks a protospacer | Anzalone 2019 | | PE4 | PE2 + MLH1dn (dominant-negative MMR) (~7.7x avg) | MMR globally | Chen 2021 | | PE5 | PE3 + MLH1dn | second nick + MMR | Chen 2021 | | PEmax | optimized protein (codon, NLS, R221K/N394K, linker); +MLH1dn = PE4max/PE5max | the protein | Chen 2021 | | PE7 | PEmax-family + La-protein RBD capping the pegRNA 3' end | pegRNA stability | Yan 2024 |
The expert move is to reason about which axis the problem needs: low efficiency in an MMR-active cell -> add MLH1dn; too many indels -> drop to PE2 or design PE3b (not PE3); short pegRNA half-life -> epegRNA/PE7. Note: in MMR-deficient lines (HCT116, many tumor lines) PE2 already behaves like PE4, so MLH1dn adds nothing -- benchmark numbers from such lines overstate the gain in MMR-proficient primary cells. PE5max + epegRNA is the modern default workhorse for hard, MMR-active contexts.
--filter_c1_extension).The pegRNA 3' extension (RTT+PBS) is single-stranded RNA that is exonucleolytically degraded before it can prime RT -- an invisible failure (the molecule is made, just chewed back). epegRNAs append a structured pseudoknot motif to the 3' end (Nelson 2022): use tevopreQ1 by default (~3-4x gain, no added off-target); mpknot is larger and benefits most from a pegLIT-designed linker (tevopreQ1/evopreQ1 often work linker-free). PE7 (La protein) attacks the same degradation from the protein side and is partly redundant with epegRNAs (PE7's gains are largest with plain pegRNAs) -- don't stack them as if independent. For synthetic (non-expressed) pegRNAs where a folded motif is awkward, PE7 / La-optimized 3' chemistry is the lever instead.
| Model | Predicts | Cite | |-------|----------|------| | PRIDICT / PRIDICT2.0 | intended-edit + unintended (indel) rate; 2.0 is chromatin-aware across lines | Mathis 2023 Nat Biotechnol 41:1151; Mathis 2025 Nat Biotechnol 43:712 | | DeepPrime / DeepPrime-FT | efficiency across 8 PE systems x 7 cell types, edits <=3 bp | Yu 2023 Cell 186:2256 | | Easy-Prime | XGBoost pegRNA design with RNA-structure features | Li 2021 Genome Biol 22:235 |
Limits: trained mostly on HEK293T + small edits; scores degrade for large edits, untrained cell types, primary/iPS cells, and in vivo loci. A high score says "worth synthesizing," not "will work in the target cell." Report edit:indel purity, not efficiency alone (PE3's indel liability hides when only the intended-edit rate is reported).
| Strategy | Mechanism | Size | Cite | |----------|-----------|------|------| | twinPE | two pegRNAs template complementary flaps -> replacement/deletion/inversion | up to ~hundreds bp; +recombinase -> kb | Anzalone 2022 Nat Biotechnol 40:731 | | GRAND editing | dual pegRNAs, RTTs complementary to each other (non-genomic) -> template-free insertion | up to a few hundred bp (drops sharply >~400 bp) | Wang 2022 | | PASTE | PE writes a serine-integrase attB site, integrase drops in a donor | ~10-36 kb, DSB-free | Yarnall 2023 Nat Biotechnol 41:500 |
Route "knock in a 2 kb reporter" to twinPE+integrase/PASTE (or HDR/HITI) -- a single giant-RTT pegRNA is a category error.
| Scenario | Recommended | Why | |----------|-------------|-----| | C->T / G->A or A->G / T->C transition, base positionable in a window | -> base-editing-design | BE is higher-efficiency, cleaner, no flap/MMR competition for its transition | | Any of the other small edits (other transversions, small indels, combined) | prime editing, panel of PBS x RTT | PE owns the precise-small-edit-without-a-DSB box | | Low efficiency in an MMR-proficient cell | PE4/PE5 (MLH1dn) + MMR-evading silent edits | MMR is the dominant barrier | | Indels unacceptable (therapeutic) | PE2 or PE3b (not PE3) | PE3's second nick raises indels | | Expressed pegRNA | add a tevopreQ1 3' motif (PE5max+epegRNA default) | fixes invisible 3'-degradation | | Large insertion (genes/tags, >~hundreds bp) | -> twinPE+integrase / PASTE / hdr-template-design | beyond single-pegRNA flap capacity | | Knockout only (any frameshift) | -> grna-design (plain Cas9) | PE's precision is wasted; nuclease is simpler/more efficient | | Validate edits | -> crispr-screens/crispresso-editing | quantify intended-edit and indel rates from amplicons |
Goal: Produce ranked pegRNA + nicking-guide candidates for a precise edit.
Approach: Encode the reference and edit in ONE inline string with PrimeDesign's exact parenthesis notation, then run the Docker CLI; it sweeps PBS/RTT, ranks pegRNAs (PAM-disrupted preferred), and nominates ngRNAs. Do not hand-roll the design as the only step.
# PrimeDesign edit-string notation (verify against the repo README; the most-hallucinated PE detail):
# substitution: ...AAACG(T/A)CTTCC... # ref/edit, slash-separated
# insertion: ...AAACGT(+CTT)CTTCC... # bare leading + (also (/CTT))
# deletion: ...AAAAC(-GTCT)TCCAAT... # bare leading - (also (GTCT/))
# combinatorial: GCCTGTGACTAACTGC(G/T)CCA(+ATCG)AAACGTC(-TTCC)AATCCCCTTATCCAATTTA
docker run -v ${PWD}/:/DATA -w /DATA pinellolab/primedesign primedesign_cli \
-f edits.csv -pbs 10 12 14 -rtt 10 16 22 -nick_dist_min 0 -nick_dist_max 100 -out designs/
Goal: Build a small, ordered panel of pegRNA extensions for one nick, applying the don't-end-on-C and 5'-G rules.
Approach: For each PBS length, take the reverse complement of the genomic sequence 5' of the nick; for each RTT length, build the edited 3' flap and reject extensions whose first templated base is C. Rank the panel by a model (PRIDICT/DeepPrime) for synthesis. (See examples/prime_editing_design.py.)
from Bio.Seq import Seq
def prepend_u6_g(spacer):
return spacer if spacer.startswith('G') else 'G' + spacer # prepend, never replace
Trigger: treating PBS/RTT as constants. Mechanism: the optimum is locus-specific (GC/Tm/nick distance/chromatin). Symptom: valid-looking pegRNA, ~2% editing. Fix: design and test a PBS x RTT panel; rank with PRIDICT2.0/DeepPrime.
Trigger: installing only the literal intended base. Mechanism: MMR reverts the edit; an intact PAM lets the editor re-nick. Symptom: low yield + indels. Fix: add a PAM-disrupting silent edit and 1-2 MMR-evading silent edits; use PE4/PE5 (MLH1dn) in MMR-active cells.
Trigger: reading the ladder as a scalar. Mechanism: PE3's second nick is a transient near-DSB. Symptom: good efficiency, unacceptable indels. Fix: if the edit makes/breaks a protospacer, design PE3b; otherwise drop to PE2/PE4.
Trigger: efficiency-only readout. Mechanism: PE yields a mix (edit/unedited/indel). Symptom: a "40%" pegRNA that throws 15% indels looks fine. Fix: report edit:indel purity (PRIDICT predicts both).
Trigger: picking the top-scored pegRNA, skipping the panel, in a non-HEK293T context. Mechanism: models are trained on HEK293T + small edits; chromatin dominates and is invisible to sequence. Symptom: "designed perfectly, didn't work." Fix: weight the model less far from training; still test; a closed locus may sink any design.
Trigger: 'G'+spacer[1:]; RTT ending on C; 2 kb into one RTT. Mechanism: spacer:target mismatch; +1-C re-incorporation; flap can't template/resolve. Fix: prepend the G; shift RTT off a terminal C; route large inserts to twinPE/PASTE.
| Parameter | Value | Source |
|-----------|-------|--------|
| PBS length | ~8-17 nt, tuned to Tm/GC (start ~24-GC%/5) | Anzalone 2019; pegFinder heuristic |
| RTT | edit + ~10-16 nt 3' homology; shortest workable | Anzalone 2019 |
| Nick-to-edit | as small as possible; efficiency falls with distance | Anzalone 2019 |
| PE3 ngRNA distance | ~40-100 bp (sweet spot ~50-90), non-edited strand | Anzalone 2019 |
| Flap +1 base | not C | Anzalone 2019 / PrimeDesign --filter_c1_extension |
| MMR inhibition gain | ~7.7x avg (MMR-proficient cells only) | Chen 2021 |
| epegRNA 3' motif | tevopreQ1 default; ~3-4x | Nelson 2022 |
| Deliverable | a ranked panel, report edit:indel purity | field practice |
| Error / symptom | Cause | Solution |
|-----------------|-------|----------|
| Editing ~2% despite a "perfect" pegRNA | fixed PBS/RTT, unfavorable locus | test a panel; consider MLH1dn/epegRNA; the locus may be closed |
| High indels with PE3 | second nick on non-edited strand | use PE3b (if the edit makes/breaks a protospacer) or PE2 |
| PrimeDesign mis-encodes the edit | wrong inline notation | use exact (ref/edit)/(+ins)/(-del); verify against the repo |
| No benefit from MLH1dn | MMR-deficient cell line | PE2 already behaves like PE4 there |
development
Installs 425 bioinformatics skills covering sequence analysis, RNA-seq, single-cell, variant calling, metagenomics, structural biology, and 56 more categories. Use when setting up bioinformatics capabilities or when a bioinformatics task requires specialized skills not yet installed.
testing
Chains a somatic (tumor-normal) SNV/indel and structural-variant pipeline end to end with GATK Mutect2 (or Strelka2), wiring the somatic-specific machinery - panel-of-normals and gnomAD germline-resource priors, GetPileupSummaries/CalculateContamination, and LearnReadOrientationModel FFPE/oxoG orientation-bias filtering fed into FilterMutectCalls. Use when calling somatic mutations from a tumor-normal pair (or tumor-only with PoN caveats), deciding which artifact filter removes which class of false positive, reasoning about VAF/purity/ploidy and clonal-vs-subclonal detection, adding somatic SV/CNV or TMB/MSI/signatures, or routing variants to AMP/ASCO/CAP tier and oncogenicity interpretation (never germline ACMG).
development
End-to-end pooled and single-cell CRISPR screen analysis from FASTQ to hit genes. Orchestrates library design QC, guide counting, six-stage screen QC (plasmid Gini, replicate Pearson, CEGv2 PR-AUC, copy-number artifact), method-appropriate hit calling across MAGeCK RRA/MLE, BAGEL2, drugZ, JACKS, and Chronos, cancer-cell-line copy-number correction (CRISPRcleanR / Chronos), batch correction for multi-batch screens, and the specialized branches for combinatorial paralog screens, single-cell Perturb-seq, base-editor variant-function screens, prime-editor screens, and in vivo bottleneck-aware screens. Use when analyzing any pooled CRISPR screen end-to-end, matching the hit-calling method to the experimental design, integrating copy-number correction into the pipeline, or branching the workflow for single-cell, combinatorial, base-editor, prime-editor, or in vivo variants.
development
Transcribe DNA to RNA and translate to protein using Biopython, with NCBI codon-table selection, CDS validation, and six-frame ORF finding. Use when converting a CDS or ORF to its amino-acid sequence, selecting a non-standard (mitochondrial, bacterial, ciliate) genetic code, validating a coding sequence, or scanning all reading frames.